Top

Gepubliceerd in:

2014 | OriginalPaper | Hoofdstuk

De medicamenteuze behandeling van stemstoornissen

juni 2001

Auteurs : H.F.M. Peters, R. Bastiaanse, J. Van Borsel, P.H.O. Dejonckere, K. Jansonius-Schultheiss, Sj. Van der Meulen, B.J.E. Mondelaers

Gepubliceerd in: Stemstoornissen

Uitgeverij: Bohn Stafleu van Loghum

Samenvatting

Wanneer een bovenste luchtweginfectie zich uit door keelpijn is er een ontsteking van het slijmvlies van farynx en/of tonsillen en/of het proximale deel van de larynx. Pas wanneer er (ook) stemverandering optreedt, is er sprake van (echte) laryngitis; de ontsteking is dan doorgedrongen tot het niveau van de stemplooien.

vorige hoofdstuk Fonochirurgische correctie van onvolledige glottissluiting en inadequate stemplooispanning

volgende hoofdstuk De behandeling van problemen bij zangers

Adams, R.A., & Victor, M. (1989). Principles of Neurology (4th ed).[] McGraw–Hill Information Services Company, 54–62; 937–943. ISBN 0–07–100122–0.

Adams, S.G., e.a. (1993). Unilateral versus bilateral botulinum toxin injections in spasmodic dysphonia: acoustic and perceptual results. Journal of Otolaryngology, 22: 171–175.

Adams, S.G. e.a. (1995). Comparison of botulinum toxin injection procedures in adductor spasmodic dysphonia. Journal of Otolaryngology, 24: 345–351.

American Academy of Neurology (1990). Report of the Therapeutics and Technology Assessment Subcommittee. Assessment the clinical usefulness of botulinum toxin–A in treating neurological disorders. Neurology, 40: 1332–1336.

Anonymus (2000). Pariet, protonpompremmer. Geneesmiddelen bulletin, 34: 61.

Aronson, A.E. & DeSanto, L.W. (1983). Adductor spastic dysphonia: three years after recurrent laryngeal nerve resection. Laryngoscope, 93: 1–8.

Berendse, H.W. (2000). Wat is de plaats van dopamine–agonisten bij de behandeling van de ziekte van Parkinson, afzonderlijk en in combinatie? Neurologen vademecum nr. 7/8 (juli/augustus).

Blitzer, A. e.a. (1988). Localized injections of botulinum toxin for the treatment of focal laryngeal dystonia (Spastic Dysphonia). Laryngoscope,98: 193–197.

Blitzer, A., e.a. (1992). Abductor laryngeal dystonia: a series treated with botulinum toxin. Laryngoscope, 102: 163–167.

Blitzer, A., e.a. (1998). Botulinum toxin management of spasmodic dysphonia (Laryngeal Dystonia): a 12–year experience in more than 900 patients. Laryngoscope, 108: 1435–1441.

Blitzer, A, & Brin, M.F. (1992). Treatment of spasmodic dysphonia (Laryngeal Dystonia) with local injections of botulinum toxin. Journal of Voice, 6: 365–369.

Boermeester, M.A., Sandick, J.W., Lanschot, J.J.B. van, Boeckxstaens, G.E., e.a. (1998). Gastro–oesofageale tefluxziekte: pathofysiologie, diagnostiek en medicamenteuze therapie. Ned.Tijdschrift Geneeskunde, 142: 1306–1310.

Bouvy, M. (1994). Farmacotherapie bij ziekte van Parkinson. Geneesmiddelen Bulletin, 28: 44–47.

Bough, I.D., Satalof; R.T., Casteel, D.O., Hills, J.R., Gideon, R.M., & Spiegel, J.R. (1995). Gastroesophageal reflux laryngitis risistant to omeprazole therapy. Journal of Voice., 9: 205–211.

Brin, M.F., e.a. (1989). Adductor laryngeal dystonia (spastic dysphonia): treatment with local injections of botulinum toxin (Botox). Movement Disorders, 4: 287–296.

Brin, M.F., e.a. (1998). Laryngeal dystonia (spasmodic dysphonia): observations of 901 patients and treatment with botulinum toxin. Advances in Neurology 78: 237–252.

Buchholz, D. W., & Neumann, S. (1997). Comments on selected dysphagia litterature. Dysphagia, 12: 57–60.

Capper, M.P., Smit, C.F., Stanojcic, L.D., Devtiese, P.P., e.a. (2000). High incidence of laryngopharyngeal reflux in patients with head and neck cancer. The Laryngoscope, 110: 1007–1011.

Cohen, J.R., Sataloff; R.T., Spiegel, J.R., Fish, J.F., e.a. (1991). Airway reactivity–induced asthma in singers (arias). Journal of Voice, 5, 332–337.

Comella, C.L., e.a. (1992). Dysphagia after botulinum toxin injections for spasmodic torticollis. Neurology, 42: 1307–1310.

Critchy, E.M.R. (1981). Speech disorders of Parkinsonism: a review. Journal of Neurology, Neurosurgery and Psychiatry, 44: 751–758.

Dedo, H.H. (1976). Recurrent laryngeal nerve section for spastic dysphonia. Annals of Otology, Rhinology & Laryngology, 85: 451–459.

Deenstra, M. (1992). De inhalatie als toedieningsvorm van geneesmiddelen. Geneesmiddelen bulletin, 26: 44–47.

Devriese, P.P. (1994). Stemband–dyskinesieën. In: Aspecten van stemstoomissen. Rapport Werkgroep Foniatrie Nederlandse Vereniging voor K.N.O.–Heelkunde en Heelkunde van het Hoofd–Halsgebied, 119–128.

Devriese, P.P., & Speelman, J.D. (1994). Behandeling van stemband–dyskinesieën. Nederlands Tijdschrift voor Geneeskunde, 138: 944–947.

Devriese, P.P. Botuline, een tweesnijdend zwaard. (1998). Geschiedenis der Geneeskunde, 5: 293–299.

Devriese, P.P. (1999). Botulinum toxin in adductor spasmodic dysphonia. Injection technique and results. Proceedings 24^th IALP–Congress, Amsterdam 1998. Dejonckere, P.H.O. & Peters, H.F.M. (Eds.). University Press, Nijmegen, 302–304.

Diagnosrisch Kompas 1999–2000. College voor Zorgverzekeringen. Keelpijn, acute, 238–239.

Farmacotherapeutisch Kompas 2000/2001. College voor Zorgverzekeringen: Overige middelen voor astma en copd, 513–515; Mucolytica, oraal, 515–519; Middelen bij hoest en verkoudheid, 484–489; Analgetica, 926–962; Middelen bij infectieziekten, Antibiotica, 697–747; Middelen bij allergische aandoeningen, Antihistaminica, 1064–1073; Glucocorticoïden, 841–850.

Farmacotherapeutisch Kompas 2000/2001. College Voor zorgverzekeringen, Anxiolytica, 69–72; Benzodiazepinen, 72–81; Antidepressiva, 110–132; Bèta–receptorblokkerende sympathicolytica, 282–299.

Farmacotherapeutisch Kompas 2000/2001. College voor zorgverzekeringen. Parkinsonmiddelen, 153–166.

Farmacotherapeutisch Kompas 2000/2001. VI Tracrus Digestivus, 415–439.

Ford, C.N., e.a. (1992). Botulinum toxin treatment of spasmodic dysphonia: techniques, indications, efficacy. Journal of Voice, 6: 370–376.

Fritzell, B., e.a. (1993). Long–term results of recurrent laryngeal nerve resection or adductor spastic dysphonia. Journal of Voice, 7: 172–178.

Gamboa, J., Jiminez–Jeminez, F., Nieto, A., Montojo, J., Orti–Paraja, M., Molina, A., e.a. (1997). Journal of Voice, 3: 314–320.

Gates, G., & Montalbo, Ph.J. (1987). The effect of low–dose ß–blockade on performance anxiety in singers. Journal of Voice, 1: 105–108.

Gates, G.A., Saegert, J., Wilson, N., Johnson, L., Shepherd,A., & Hearne, E.M. (1985). Annals Otol. Rhino. Laryngol., 94: 570–574.

Green, D.C., e.a. (1992). Point–touch technique of botulinum toxin injection for the treatment of spasmodic dysphonia. Annals of Otology, Rhinology & Laryngology, 101: 883–887.

Hacki, T., Kenklies, M., Hofman, R., e.a.. (1990). Pharmakotherapie von Stimm– und Artikulationsstorungen bei Aphasie. Folia Phoniatrica, 42: 283–288.

Hanson, D.G., Garrat, B.R., Ward, P.H., & Los Angelas, C.A. (1984). Cinegraphic observations of laryngeal function in Parkinson's disease. Laryngoscope, 94: 348–353.

Hanson, D.G., Jiang, J.J., Chen, J., e.a. (1997). Acoustic measurement of change in voice quality with treatment for chronic posterior laryngitis. Ann. Otologyl, Rhinology Laryngo1ogy, 106: 279–285.

Hartley, L.R., Ugapen, S., Davie, I., & Spencer, D.J. (1983). The effect of beta–adrenergic blocking drugs on speakers' performance and memory. British Journal Psychiatry, 142: 512–517.

Hollinger, L.E. (1986). Pharmacotherapeutic considerations in anxiety disorders. Journal Clonical Psychiatry, 47 (Suppl. June): 33–36.

Holzer, S.E., & Ludlow, C.L. (1996). The swallowing side effects of botulinum toxin type A injection in spasmodic dysphonia. Laryngoscope, 106: 86–92.

Izdebski, K., e.a. (1981). Postoperative and follow–up studies of spastic dysphonia patients treated with recurrent laryngeal nerve section. Otolaryngol. Head Neck Surgery, 89: 96–101.

Jansen, E.N.H., & Laar, T. van (1990). ‘Oude wijn in nieuwe zakken’; therapie mer subcurane apomorfine bij de ziekre van Parkinson. Ned. Tijdschrift voor Geneeskunde, 134: 889–891.

Jiang, J., Lin, E., Wang, J., e.a. (1999). Glottografic measures before and after Levodopa treatment in Parkinson's disease. The Larynoscope, 109: 1287–1294.

Jong, de P.T.V.M., e.a. (1991). Vijftien jaar therapeutisch toepassen van botuline A toxine. In: J.C. van Es, E. Mandema, G. Olthus, E. Verstraete (red.), Het Medisch Jaar 1991. Houten/Antwerpen: Bohn Stafleu Van Loghum, 274–277.

Klinkenberg–Knol, E.C. (1992). The role of omeprazole in healing and prevention of reflux disease. Hepatogastroenterology, 39 (Suppl 1): 27–30.

Klinkenberg–Knol, E.C., Festen, H.P.M., Jansen, J.B.M., Lamers, C.B.H.W., e.a. (1994). Long–term treatment with omeprazol for refractory reflux esophagitis: efficacy and safety. Anno Intern Med. 121: 161–167.

Kobayashi, T., e.a. (1993). Botulinum toxin treatment for spasmodic dysphonia. Acta Oto–Laryngologica (Suppl. 504): 155–157.

Kompoliti, K., Wang, Q.E., Goetz, C.G., Leurgans, S., & Raman, R. (2000). Effects of central dopaminergic stimulation by apomorphine on speech in Parkinson's disease. Neurology, 54: 458–462.

Koriwchak, M.J., e.a. (1996). Alternating unilateral botulinum toxin type A (BotoX) injections for spasmodic dysphonia. Laryngoscope, 106: 1476–1481.

Koufman, J.A. (1991). The otolaryngologic manifestation of gastroesophageal reflux disease (gerd): a clinical investigation of 225 patients using ambulatoty 24–hours pH monitoring and an experimental investigation of the role of acid and pepsin in the development oflaryngeal injuty. The Laryngoscope, 101 (Supp1 53): 1–78.

Kumazawa, H., Asako, M.,Yamashita, T., e.a. (1997). An increase in laryngeal aerosol deposition by ultrasonic nebulizer therapy with interrnitrend vocalisation. The Larynsoscope, 107: 671–674.

Lader, M. (1988). ß–Adrenoceptor antagonists in neuropsychiatry: An update. Journal Clincal. Psychiatr.,49: 213–223.

Langeveld, T.P. (1998). Unilateral versus bilateral botulinum toxin injections in adductor spasmodic dysphonia. Annals of Otology, Rhinology & Laryngology, 107: 280–284.

Levine, H.L., e.a. (1979). Recurrent laryngeal nerve section for spasmodic dysphonia. Annals of Otology & Laryngology, 88: 527–530.

Liu, T.C., e.a. (1996). Prospective study of patients' subjective responses to botulinum toxin injections for spasmodic dysphonia. Journal of Otolaryngology, 25: 66–74.

Liu, C.Y. (1998). Emotional Symptoms are secundary to the voice disorder in patients with spasmodic dysphonia. General Hospital Psychiatry, 20: 255–259.

Ludlow, C.L., e.a. (1988). Effects of botulinum toxin injections on speech in adductor spasmodic dysphonia. Neurology, 38: 1220–1225.

Ludlow, C.L., e.a. (1992). A comparison of injection techniques using botulinum toxin injection for treatment of the spasmodic dysphonias. Journal of Voice, 6: 380–386.

Lundy, D.S. (1998). The effect of patient factors on response outcomes to Botox treatment of spasmodic dysphonia. Journal of Voice, 12: 460–466.

Miller, R.H., e.a. (1987). Botulinum toxin injection of the vocal cord for spasmodic dysphonia. A preliminary report. Archives of Otolaryngology – Head and Neck Surgery, 113: 603–605.

Murry, T., & Woodson, G.E. (1995). Combined–modality treatment of adductor spasmodic dysphonia with botulinum toxin and voice therapy. Journal of Voice, 9: 460–465.

Perry, P.J., Alexander, B., & Liskow, B.I. (1997). Psychiatric Drug Handbook(7th. ed.)Antianxiety Agents (Anxiolytics)–ß–Blockers, 330–331. ISBN 0–88048–851–4.

Ramig, L.O. & Verdolini, K. (1998). Treatment efficacy: voice disorders. Speech and Hearing Research, 41: 101–116.

Rhew, K., e.a. (1994). Technique for injection of botulinum toxin through the flexible nasolaryngoscope. Otolaryngology – Head & Neck Surgery, 111: 787–794.

Roos, R.A.C., Laar, T. van & Hilren, J.J. van (1994). Beperkte waarde van de apomorfinetest bij de ziekte van Parkinson. Ned. Tijdschrift voor Geneeskunde, 138: 1374–1377.

Schalén, L., Eliasson, I., Kamme, C., e.a. (1993). Erythromycin in acute laryngitis in adults. An. Otol. Rhinol. Laryngologie, 102: 209–214.

Scott, A.B. (1980). Botulinum toxin injection into extraocular muscles as an alternative to strabismus surgery. Ophthalmology 87: 1044–1049.

Sellin, C. (1981). The action of botulinum toxin at the neuromuscular junction. Medical Bio1ogy, 59: 11–20.

Shaw, G.Y., & Searl, J.P. (1997). Laryngeal rnanifestation of gastroesophageal reflux before and after treatment with omeprezole. South Med Journal,90: 1115–1122.

Speelman, J.D., e.a. (1996). Neurological indications for botulinum treatment. Proceedings of Biomedical Aspects of Clostridial Neurotoxins. Ranter, H.S. (ed.). Oxford Conference 1996. camr, 85–88.

Tewary, A.K. (1996). Correlation between clinical response and injection quality in treatment of spasmodic dysphonia. Journal of Laryngology & Otology, 110: 551–553.

Tison, F., Wiart, L., Guatterie, M., Fouiller, N., Lozano, V., e.a. (1996). Effect of central dopaminergic stimulation by apomorphine on swallowing disorders in Parkinson's disease. Moving Disorders, 11: 729–732.

Toogood, J.H. (1990). Complications of topical steroid therapy for asthma. Am. Rev. Respir. Des., 141: 89–96.

Toogood, J.H., Jennings, B., Greenway, R.W., e.a. (1980). Journal Allergy, Clinical Immunology, 65: 145–153.

Truong, D.D, e.a. (1991). Double–blind controlled study of botulinum toxin in adductor spasmodic dysphonia. Laryngoscope, 101: 630–634.

Uijen, J.H.J.M., Ponsioen, B.P., & Jongste, J.C. (1994). Inhalatiemedicatie: toedieningsvormen en hulpmiddelen. Een literatuuronderzoek. Huisarts en Wetenschap, 37: 194–197.

Van Ermengem E. (1897). Ueber einen neuen anaëroben Bacillus und seine Beziehungen zum Botulismus. Zeitschrift für Hygiene und Infektionskrankheiten (Leipzig), 26: 1–56.

Whurr, R., e.a. (1993). The use of botulinum toxin in the treatment of adductor spasmodic dysphonia. Journal of Neurology, Neurosurgery & Psychiatry, 56: 526–530.

Whurr, R., e.a. (1995). Comparison of dosage effects between the American and British botulinum toxin A products in the treatment of spasmodic dysphonia (abstract). Movement Disorders, 10: 387.

Wijngaarden, H.A. van (1977). De invloed van geluid op het neerslaan van ingeademde nevel. Proefschrift. Utrecht: Rijksuniversiteit te Utrecht.

Wijngaarden, H.A. van (1983). De behandeling van acute stemklachten door laryngitis. Logopedie en Foniatrie, 55: 389–393.

Wijngaarden, HA. van, Hoekstra, A., Damsté, P.H., & Fokkens, J.K. (1978). Is it useful to apply aerosol therapy for laryngeal diseases? Niet–gepubliceerd onderzoekverslag.

Williams, A.J., Baghar, M.S., Stableforth, D.E., e.a. (1983). Dysphonia caused by inhalation steroids: recognition of a characretistic laryngeal abnormality. Thorax, 38: 813–821.

Wilson, J.A., White,A., Haacke, N.P. von, Maran, A.G.D., Heading, R.C., Pryde, A., & Pris, J. (1989). Gastroesophageal reflux and posterior laryngitis. Anno Oto. Rhino. Laryngol, 98: 405–410.

Wiltink, E.H.H., e.a. (1992). Botuline: een toxine als therapeuticum. Pharmaceutisch Weekblad, 127: 1037–1041.

Wolters, E.Ch, & Groenewegen, H.J. (1996). Neurologie: Structuur, functie en dysfunctie van het zenuwstelsel. Houten: Bohn Stafleu Van Loghum.

Yin, S.S., e.a. (1997). Major patterns of laryngeal electromyography and their clinical application. Laryngoscope, 107: 126–136.

Yorkston, K.M. (1996). Treatment efficacy: dysarthria. Journal Speech and Hearing Research, 39: S46–57.

Zwirner, P., e.a. (1993). A comparison of bilateral and unilateral botulinum toxin treatments for spasmodic dysphonia. European Archives of Oto–Rhino–Laryngology, 250: 271–276.

Blitzer, A., e.a. (1992). Neurolgic Disorders of the Larynx. NewYork: Thieme.

Brin, M.F., e.a. (1998). Laryngeal dystonia (Spasmodic Dysphonia): Observations of 901 patients and treatment with botulinum toxin. Advances in Neurology, 78: 237–252.

Titel: De medicamenteuze behandeling van stemstoornissen
Auteurs: H.F.M. Peters
R. Bastiaanse
J. Van Borsel
P.H.O. Dejonckere
K. Jansonius-Schultheiss
Sj. Van der Meulen
B.J.E. Mondelaers
Uitgeverij: Bohn Stafleu van Loghum
Boek: Stemstoornissen
Print ISBN: 978-90-368-0807-1

Elektronisch ISBN: 978-90-368-0808-8

Copyright: 2014
DOI: https://doi.org/10.1007/978-90-368-0808-8_42

Bohn Stafleu van Loghum

Deel dit onderdeel of sectie (kopieer de link)

Samenvatting

Log in om toegang te krijgen